4DMedical valuation

4DX · ASX · AUD

Compare 4DMedical
$2.16Change from previous close: −4.42%Absolute change: −$0.10

Close · November 20, 2026

Valuation

The average price target of 3 analysts is $4.17.

Data as of November 22, 2026

4DMedical compared with similar companies

4DMedical's Price/book: 7.58, +31% against the median of a group of 7 similar companies (5.80).

4DMedical's metrics compared with similar companies
Metric4DMedicalMedian25th–75th percentileBand
Price/book7.585.804.13 – 13.9Middle
Price/sales184.212.57.14 – 54.8High
Gross margin93.8%75.0%58.0% – 90.3%High
Operating margin-813.7%19.5%-71.5% – 28.5%Low
Net margin0.0%12.8%-6.3% – 25.2%Middle
ROE-174.4%11.8%-19.8% – 14.1%Low
Debt/equity1.060.080.02 – 0.70High

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$1.3B
Enterprise value
$1.2B
P/E (trailing 12 months)
-11.4
Forward P/E
-81.5
EV/EBITDA
-21.5
EV/revenue
170.2

Profitability and growth

ROA
-15.6%
ROIC
-17.1%
Revenue growth (year over year)
42.3%
Earnings growth (year over year)
124.6%

Financial health

Total cash
$277.95M
Total debt
$180.24M
Current ratio
30.8
Quick ratio
30.5
Altman Z-Score
3.79
Piotroski F-Score
3.00

Dividends

Dividend yield
0.0%

Analysts and estimates

Average price target
$4.17
Median price target
$4.10
High price target
$6.00
Low price target
$2.40
Analysts with a price target
3
Forward EPS
-$0.03
EPS estimate, current year
-$0.06

Shares and trading

Beta
1.94
Average volume
4.49M
Shares outstanding
602.34M
Float
498.38M
Institutional ownership
25.3%
Insider ownership
16.6%